Skip Navigation
Nora Disis
We fund research that changes women’s lives

The Rivkin Center acts as a catalyst in the ovarian cancer research community, incubating projects that precipitate vastly greater quantity and depth of scientific inquiry.See the return on our investment dollars.

Grants for ovarian cancer research

Every year, the Rivkin Center funds promising research in ovarian cancer, selecting researchers and studies through a highly competitive process. Each application is individually reviewed by a panel of nationally recognized experts for its scientific merit, novelty, and potential to affect the prevention, detection, treatment, and understanding of the disease. Our scientific funding is done through various streams:

Pilot Study Awards

Investigators often struggle to find funding for innovative approaches to scientific questions because their new ideas may not yet be in the scientific mainstream. Each year we support multiple pilot studies with $75,000 each to pave the way for new avenues of ovarian cancer research and to expand our understanding of the disease.

See Pilot Studies

Scientific Scholar Awards

Young, talented investigators often have novel ideas and fresh approaches to scientific challenges. In order to attract new investigators to ovarian cancer research, each year we support multiple Scientific Scholars with $60,000 each for their proposed research. Each award recipient names a mentor who will help guide him or her through the process of becoming an established researcher.

See Scholar Awards

Bridge Funding Awards

Federal funding for research is tighter than ever, and often researchers do not get funded on their first try with a new proposal. The purpose of Bridge Funding is to allow researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. In order to be competitive, resubmitted proposals must include solid data and address the concerns of expert reviewers. The Rivkin Center provides interim funding of up to $30,000 for six months to researchers who have submitted to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who were not funded but received a score close to the funding threshold. With more data, ovarian cancer researchers stand a better chance of being successfully funded with a stronger, resubmitted proposal.

See Bridge Funding Awards

Challenge Grants

Challenge grants in scientific research revolve around the posing of a grand scientific question to the research community and asking researchers to submit their best ideas for meeting the challenge with creative solutions. With help from our Scientific Advisory Board, the Rivkin Center identifies areas in ovarian cancer research in which the greatest strides can be made today and offers a 2-year, $150,000 Challenge Grant to the research group that proposes the best solution.

See Challenge Grants

Our supported programs fill an important need

Early detection is paramount

The Ovarian Cancer Early Detection Screening Program, funded by the Rivkin Center through December 2015, used CA-125 blood tests and annual ovarian ultrasounds to help detect ovarian cancer early in women at high risk for ovarian cancer. Not only did this program provide women with access to novel biomarkers for ovarian cancer screening when they became available, but it also provided researchers with tools to identify additional blood markers that might complement the CA-125 blood test. The Early Detection Screening Program is continued through Swedish Medical Center.

Learn About the Program

National research meeting

The Ovarian Cancer Research Symposium is the longest-running national research conference dedicated exclusively to ovarian cancer. The biennial event provides a national focus for ovarian cancer research and allows for the development of collaborative research links.

See the Symposium

Building a resource for the future

The Rivkin Center-Sponsored Tissue Bank currently contains over 200,000 distinct blood/tissue samples and patient data, which is used by researchers to assist in the identification of new diagnostic and early detection tools.

Pilot Study Award

Scientist in lab

Pilot Study Submission Deadline

The grant competition is open September 1 – December 1. To be eligible, applications must be received by December 1, 2016 (5pm PST)

Apply Now

The long-term disease-free survival rate for advanced ovarian cancer is 10%
The overall 10-year survival rate for ovarian cancer patients is 35%
If diagnosed and treated before it spreads outside the ovaries, the 5-year survival rate is 92%